Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics

被引:119
作者
Kheirelseid, Elrasheid A. H. [1 ]
Jumustafa, Hanzali [1 ]
Miller, Nicola [1 ]
Curran, Catherine [1 ]
Sweeney, Karl [1 ]
Malone, Carmel [1 ]
McLaughlin, Ray [1 ]
Newell, John [2 ]
Kerin, Michael J. [1 ]
机构
[1] Natl Univ Ireland Galway, Dept Surg, Inst Clin Sci, Galway, Ireland
[2] Natl Univ Ireland Galway, Inst Clin Sci, Biostat Unit, Galway, Ireland
关键词
Breast cancer; Bilateral breast cancer; Synchronous breast cancer; Contralateral breast cancer; CONTRALATERAL PROPHYLACTIC MASTECTOMY; RISK-FACTORS; 1ST PRIMARY; CARCINOMA; WOMEN; EPIDEMIOLOGY; TRIAL; MRI; RADIOTHERAPY; TAMOXIFEN;
D O I
10.1007/s10549-010-1057-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There has been conflicting evidence on the impact of bilateral breast cancer (BBC) on the survival and management of patients. The objectives of this study were to address the incidence of BBC and to investigate its characteristics and outcome compared to unilateral cancer. Data were acquired from the prospectively maintained NUIG breast cancer database between 1988 and 2008. BBC were then categorized as synchronous (within 12 months) or metachronous (after 12 months of first tumour). SPSS was used for data analysis. The incidence of BBC in our population was 4.4% (112 of 2,524). Of those 2.1% were synchronous while 2.3% were metachronous. Compared to unilateral cases, bilateral cancer patients were younger (P = 0.021) and had smaller size (P = 0.001) and earlier stage (P < 0.001) tumours at diagnosis. We identified the HER2/neu positivity as a risk factor for developing contralateral breast tumour and ER negativity as a risk factor for developing metachronous tumours. While there was no significant difference in survival for patients with bilateral compared to unilateral tumour (P > 0.05), the synchronous tumour was associated with poorer survival (P = 0.010) in comparison to metachronous tumour. This large single-institutional experience does not support the increasing practice of prophylactic mastectomy but does justify regular follow-up with mammography for early detection of contralateral tumour.
引用
收藏
页码:131 / 140
页数:10
相关论文
共 56 条
[1]  
Abdalla I, 2000, CANCER J, V6, P266
[2]  
ADAMI HO, 1985, CANCER-AM CANCER SOC, V55, P643, DOI 10.1002/1097-0142(19850201)55:3<643::AID-CNCR2820550328>3.0.CO
[3]  
2-L
[4]   Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients [J].
Bedrosian, Isabelle ;
Hu, Chung-Yuan ;
Chang, George J. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (06) :401-409
[5]   RISK-FACTORS PREDICTING THE INCIDENCE OF 2ND PRIMARY BREAST-CANCER AMONG WOMEN DIAGNOSED WITH A 1ST PRIMARY BREAST-CANCER [J].
BERNSTEIN, JL ;
THOMPSON, WD ;
RISCH, N ;
HOLFORD, TR .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 136 (08) :925-936
[6]   Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the women's environment, cancer and radiation epidemiology study [J].
Bertelsen, Lisbeth ;
Bernstein, Leslie ;
Olsen, Jorgen H. ;
Mellemkjaer, Lene ;
Haile, Robert W. ;
Lynch, Charles F. ;
Malone, Kathleen E. ;
Anton-Culver, Hoda ;
Christensen, Jane ;
Langholz, Bryan ;
Thomas, Duncan C. ;
Begg, Colin B. ;
Capanu, Marinela ;
Ejlertsen, Bent ;
Stovall, Marilyn ;
Boice, John D., Jr. ;
Shore, Roy E. ;
Bernstein, Jonine L. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (01) :32-40
[7]  
Boetes C, 2005, Cancer Imaging, V5 Spec No A, pS10, DOI 10.1102/1470-7330.2005.0040
[8]   CANCER IN THE CONTRALATERAL BREAST AFTER RADIOTHERAPY FOR BREAST-CANCER [J].
BOICE, JD ;
HARVEY, EB ;
BLETTNER, M ;
STOVALL, M ;
FLANNERY, JT .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (12) :781-785
[9]  
BRENNER H, 1993, CANCER, V72, P3629, DOI 10.1002/1097-0142(19931215)72:12<3629::AID-CNCR2820721213>3.0.CO
[10]  
2-T